Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Del Re, E C ^a,b   Bergen, S E ^b,c,d   Mesholam Gately, R I ^b,e   Niznikiewicz, M A ^a,b   Goldstein, J M ^b,c,f   Woo, T U ^b,e,g   Shenton, M E ^a,f   Seidman, L J ^b,c,e   McCarley, R W ^a,b   Petryshen, T L ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; BIOLOGICAL MARKER; KRUPPEL LIKE FACTOR; ZNF804A PROTEIN, HUMAN;

ADULT; ALERTNESS; ARTICLE; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH NEGATIVITY; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; SCHIZOPHRENIA; SELECTIVE ATTENTION; SOUND; WORKING MEMORY; ALLELE; ATTENTION; AUDITORY STIMULATION; BRAIN REGION; ELECTRODE; ELECTROPHYSIOLOGY; GENOTYPE; INTELLIGENCE QUOTIENT; P300B AMPLITUDE; SOCIAL STATUS; SOUND RELATED PHENOMENA; ZNF804A GENE; ADOLESCENT; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION; BIOLOGICAL MARKERS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84893417901     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.117     Document Type: Article

References (100)

1. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192. (Pubitemid 37494071)
2. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 2009; 373: 234-239.
3. Bergen SE, Petryshen TL. Genome-wide association studies of schizophrenia: does bigger lead to better results? Curr Opin Psychiatry 2012; 25: 76-82.
4. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-1055.
5. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
6. Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry 2011; 16: 59-66.
7. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L et al. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 2011; 16: 429-441.
8. Schwab SG, Kusumawardhani AA, Dai N, Qin W, Wildenauer MD, Agiananda F et al. Association of rs1344706 in the ZNF804A gene with schizophrenia in a case/control sample from Indonesia. Schizophr Res 2013; 147: 46-52.
9. Zhang R, Yan JD, Valenzuela RK, Lu SM, Du XY, Zhong B et al. Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706. Schizophr Res 2012; 141: 40-47.
10. Zhang R, Valenzuela RK, Lu S, Meng L, Guo T, Du X et al. Is the conserved mammalian region of ZNF804A locus associated with schizophrenia? A population-based genetics analysis. Schizophr Res 2011; 133: 159-164.
11. Walters JT, Corvin A, Owen MJ, Williams H, Dragovic M, Quinn EM et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry 2010; 67: 692-700.
12. Agnew-Blais J, Seidman LJ. Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: A quantitative and qualitative review. Cogn Neuropsychiatry 2013; 18: 44-82.
13. Thermenos HW, Keshavan MS, Juelich RJ, Molokotos E, Whitfield-Gabrieli S, Brent BK et al. A review of neuroimaging studies of young relatives of individuals with schizophrenia: A developmental perspective from schizotaxia to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2013; 162: 604-635.
14. McCarley RW, Nakamura M, Shenton ME, Salisbury DF. Combining ERP and structural MRI information in first episode schizophrenia and bipolar disorder. Clin EEG Neurosci 2008; 39: 57-60. (Pubitemid 351644612)
15. Michie PT, Innes-Brown H, Todd J, Jablensky AV. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biol Psychiatry 2002; 52: 749-758.
16. Price GW, Michie PT, Johnston J, Innes-Brown H, Kent A, Clissa P et al. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biol Psychiatry 2006; 60: 1-10.
17. Hall MH, Schulze K, Rijsdijk F, Kalidindi S, McDonald C, Bramon E et al. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med 2009; 39: 1277-1287.
18. Knight RT. Decreased response to novel stimuli after prefrontal lesions in man. Electroencephalogr Clin Neurophysiol 1984; 59: 9-20. (Pubitemid 14128147)
19. Mathalon DH, Hoffman RE, Watson TD, Miller RM, Roach BJ, Ford JM. Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder. Front Hum Neurosci 2010; 3: 70.
20. Mondragon-Maya A, Solis-Vivanco R, Leon-Ortiz P, Rodriguez-Agudelo Y, Yanez-Tellez G, Bernal-Hernandez J et al. Reduced P3a amplitudes in antipsychotic naive first-episode psychosis patients and individuals at clinical high-risk for psychosis. J Psychiatr Res 2013; 47: 755-761.
21. Turetsky BI, Cannon TD, Gur RE. P300 subcomponent abnormalities in schizophrenia: III. Deficits In unaffected siblings of schizophrenic probands. Biol Psychiatry 2000; 47: 380-390. (Pubitemid 30110610)
22. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull 2007; 33: 69-94. (Pubitemid 46026260)
23. Squires NK, Squires KC, Hillyard SA. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 1975; 38: 387-401.
24. Ranganath C, Rainer G. Neural mechanisms for detecting and remembering novel events. Nat Rev Neurosci 2003; 4: 193-202. (Pubitemid 37280184)
25. Polich J. Updating P300: An integrative theory of P3a and P3b. Clin Neurophysiol 2007; 118: 2128-2148. (Pubitemid 47385341)
26. Dien J, Spencer KM, Donchin E. Localization of the event-related potential novelty response as defined by principal components analysis. Brain Res Cogn Brain Res 2003; 17: 637-650. (Pubitemid 38373369)
27. Sokolov EN. Higher nervous functions; the orienting reflex. Annu Rev Physiol. 1963; 25: 545-580.
28. Knight R. Contribution of human hippocampal region to novelty detection. Nature 1996; 383: 256-259. (Pubitemid 26317674)
29. Yamaguchi S, Hale LA, D'Esposito M, Knight RT. Rapid prefrontal- hippocampal habituation to novel events. J Neurosci 2004; 24: 5356-5363. (Pubitemid 38747677)
30. Axmacher N, Cohen MX, Fell J, Haupt S, Dumpelmann M, Elger CE et al. Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens. Neuron 2010; 65: 541-549.
31. Menon V, Uddin LQ. Saliency, switching, attention and control: A network model of insula function. Brain Struct Funct 2010; 214: 655-667.
32. Bressler SL, Menon V. Large-scale brain networks in cognition: emerging methods and principles. Trends Cogn Sci 2010; 14: 277-290.
33. Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003; 54: 40-48. (Pubitemid 36776722)
34. Golimbet V, Gritsenko I, Alfimova M, Lebedeva I, Lezheiko T, Abramova L et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry 2006; 7: 238-245. (Pubitemid 44650533)
35. Bramon E, Shaikh M, Broome M, Lappin J, Berge D, Day F et al. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 2008; 41: 553-560.
36. Kang C, Yang X, Xu X, Liu H, Su P, Yang J. Association study of neuregulin 1 gene polymorphisms with auditory P300 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 422-428.
37. Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N, Winterer G. ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology 2009; 34: 641-650.
38. Donohoe G, Morris DW, De Sanctis P, Magno E, Montesi JL, Garavan HP et al. Early visual processing deficits in dysbindin-associated schizophrenia. Biol Psychiatry 2008; 63: 484-489. (Pubitemid 351220791)
39. Jablensky A, Morar B, Wiltshire S, Carter K, Dragovic M, Badcock JC et al. Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes Brain Behav 2011; 10: 410-417.
40. Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, Pearson JV et al. Common Kibra alleles are associated with human memory performance. Science 2006; 314: 475-478. (Pubitemid 44628970)
41. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Purcell S et al. Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr Res 2007; 92: 181-188. (Pubitemid 46561218)
42. Carless MA, Glahn DC, Johnson MP, Curran JE, Bozaoglu K, Dyer TD et al. Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes. Mol Psychiatry 2011; 16: 1096-1104, 1063.
43. Esslinger C, Kirsch P, Haddad L, Mier D, Sauer C, Erk S et al. Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A. Neuroimage 2011; 54: 2514-2523.
44. Donohoe G, Rose E, Frodl T, Morris D, Spoletini I, Adriano F et al. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Neuroimage 2011; 54: 2132-2137.
45. Lencz T, Szeszko PR, DeRosse P, Burdick KE, Bromet EJ, Bilder RM et al. A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology 2010; 35: 2284-2291.
46. Woods SW, Miller TJ, McGlashan TH. The 'prodromal' patient: both symptomatic and at-risk. CNS Spectr 2001; 6: 223-232. (Pubitemid 32547954)
47. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999; 70: 273-287.
48. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006; 113: 247-272.
49. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-164. (Pubitemid 32142753)
50. Schultze-Lutter F, Klosterkotter J, Picker H, Steinmeyer E-M, Ruhrmann S. Predicting first-episode psychosis by basic symptom criteria. Clinical Neuropsychiatry 2007; 4: 11-22. (Pubitemid 47072411)
51. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800-805.
52. Stoll AL. The Psychopharmacology Reference Card. McLean Hospital: Belmont, MA, USA 2001.
53. Hollingshead AB. Two Factor Index of Social Position. Yale University Press: New Haven, CT, USA, 1975.
54. McCarley RW, Shenton ME, O'Donnell BF, Faux SF, Kikinis R, Nestor PG et al. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 1993; 50: 190-197. (Pubitemid 23077473)
55. Niznikiewicz MA, Spencer KM, Dickey C, Voglmaier M, Seidman LJ, Shenton ME et al. Abnormal pitch mismatch negativity in individuals with schizotypal personality disorder. Schizophr Res 2009; 110: 188-193.
56. Gratton G, Coles MG, Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983; 55: 468-484. (Pubitemid 13112654)
57. Wilkinson GS, Robertson G.J. Wide Range Achievement Test-Fourth Edition. Psychological Assessment Resources: Lutz, FL, USA, 2006.
58. Wechsler D. Wechsler Abbreviated Scale of Intelligence. Psychological Corporation, Harcourt Brace: New York, NY, USA, 1999.
59. Seidman LJ, Breiter HC, Goodman JM, Goldstein JM, Woodruff PW, O'Craven K et al. A functional magnetic resonance imaging study of auditory vigilance with low and high information processing demands. Neuropsychology 1998; 12: 505-518. (Pubitemid 28487731)
60. Seidman LJ, Meyer EC, Giuliano AJ, Breiter HC, Goldstein JM, Kremen WS et al. Auditory working memory impairments in individuals at familial high risk for schizophrenia. Neuropsychology 2012; 26: 288-303.
61. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
62. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missingdata inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007; 81: 1084-1097. (Pubitemid 47580259)
63. International HapMap Consortium, Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58.
64. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
65. Steinberg S, de Jong S, Irish Schizophrenia Genomics Consortium, Andreassen OA, Werge T, Borglum AD et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 2011; 20: 4076-4081.
66. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
67. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
68. Pe'er I, Yelensky R, Altshuler D, Daly MJ. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 2008; 32: 381-385. (Pubitemid 351656309)
69. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2011; 168: 930-946.
70. Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry 2006; 11: 1062-1065. (Pubitemid 44863428)
71. Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC et al. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry 2008; 63: 42-48. (Pubitemid 350234878)
72. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 990-995.
73. Tsai SJ, Yu YW, Chen TJ, Chen JY, Liou YJ, Chen MC et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003; 338: 123-126. (Pubitemid 36140153)
74. Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A et al. Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia. Neuropsychopharmacology 2010; 35: 368-373.
75. Narr KL, Szeszko PR, Lencz T, Woods RP, Hamilton LS, Phillips O et al. DTNBP1 is associated with imaging phenotypes in schizophrenia. Hum Brain Mapp 2009; 30: 3783-3794.
76. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Berja A et al. Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. Neuroimage 2010; 53: 1016-1022.
77. Kohannim O, Hibar DP, Jahanshad N, Stein JL, Hua X, Toga AW et al. Predicting temporal lobe volume on MRI from genotypes using L(1)-L(2) regularized regression. Proc IEEE Int Symp Biomed Imaging 2012; 1160-1163.
78. Pomarol-Clotet E, Fatjo-Vilas M, McKenna PJ, Monte GC, Sarro S, Ortiz-Gil J et al. COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects. Neuroimage 2010; 53: 899-907.
79. Wang D, Liu B, Qin W, Wang J, Zhang Y, Jiang T et al. KIBRA gene variants are associated with synchronization within the default-mode and executive control networks. Neuroimage 2013; 69: 213-222.
80. Hill MJ, Bray NJ. Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development. Am J Psychiatry 2012; 169: 1301-1308.
81. Hill MJ, Jeffries AR, Dobson RJ, Price J, Bray NJ. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum Mol Genet 2012; 21: 1018-1024.
82. Girgenti MJ, LoTurco JJ, Maher BJ. ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. PLoS One 2012; 7: e32404.
83. Polich J, Criado Jr. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006; 60: 172-185. (Pubitemid 43776735)
84. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, McMichael GO et al. Replication of association between schizophrenia and ZNF804A in the Irish casecontrol study of schizophrenia sample. Mol Psychiatry 2010; 15: 29-37.
85. Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Arnold C et al. Neural mechanisms of a genome-wide supported psychosis variant. Science 2009; 324: 605.
86. Grillon C, Courchesne E, Ameli R, Geyer MA, Braff DL. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence. Arch Gen Psychiatry 1990; 47: 171-179. (Pubitemid 20058093)
87. Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: A quantitative and qualitative review. Curr Pharm Des 2012; 18: 399-415.
88. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology 2009; 23: 315-336.
89. Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL, Light GA. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med 2012; 42: 85-97.
90. Devrim-Ucok M, Keskin-Ergen HY, Ucok A. Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1426-1434. (Pubitemid 44634953)
91. Voineskos AN, Lerch JP, Felsky D, Tiwari A, Rajji TK, Miranda D et al. The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses. Neuropsychopharmacology 2011; 36: 1871-1878.
92. O'Donoghue T, Morris DW, Fahey C, Costa AD, Moore S, Cummings E et al. Effects of ZNF804A on auditory P300 response in schizophrenia. Transl Psychiatry 2014 (this issue). 93 Spencer KM, Dien J, Donchin E. Spatiotemporal analysis of the late ERP responses to deviant stimuli. Psychophysiology 2001; 38: 343-358.
93. Spencer KM, Dien J, Donchin E. A componential analysis of the ERP elicited by novel events using a dense electrode array. Psychophysiology 1999; 36: 409-414. (Pubitemid 29237441)
94. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001; 49: 1-52. (Pubitemid 32451739)
95. Fornito A, Bullmore ET. Connectomic intermediate phenotypes for psychiatric disorders. Front Psychiatry 2012; 3: 32.
96. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR. Altered cortical network dynamics: A potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 2011; 68: 1207-1217.
97. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005; 62: 379-386. (Pubitemid 40471687)
98. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 2001; 935: 107-117. (Pubitemid 32511395)
99. Wassink TH, Epping EA, Rudd D, Axelsen M, Ziebell S, Fleming FW et al. Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 2012; 69: 885-892.
100. Walter H, Schnell K, Erk S, Arnold C, Kirsch P, Esslinger C et al. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry 2011; 16: 462-470.